Lymphangioma, anys site

CD2_BENIGN_LYMPHANGIOMA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D18.1& Hospital discharge: ICD-9 — 2281 Hospital discharge: ICD-8 — 22701 Cause of death: ICD-10 — D18.1& Cause of death: ICD-9 — 2281 Cause of death: ICD-8 — 22701 2 out of 7 registries used, show all original rules.	286
4. Check minimum number of events None	286
5. Include endpoints None	286
6. Filter based on genotype QC (FinnGen only)	286

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D18
Name in latin: Lymphangioma (quovis hoco)

NAME	CD2_BENIGN_LYMPHANGIOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D181
HD_ICD_9	2281
HD_ICD_8	22701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D181
COD_ICD_9	2281
COD_ICD_8	22701
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lymphangioma, anys site based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Lymphangioma, anys site

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2976	1458	1511
Only index persons	2551	1253	1298
Unadjusted period prevalence (%)
Whole population	0.04	0.04	0.04
Only index persons	0.05	0.05	0.05
Median age at first event (years)
Whole population	16.06	17.67	14.29
Only index persons	18.56	20.72	16.47

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	286	176	110
Unadjusted period prevalence (%)	0.06	0.06	0.05
Median age at first event (years)	31.79	32.77	30.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
256: Matched controls
2561

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D18.1

ICD-10 Finland

Lymphangioma, any site

9457.4

257.4

203

D18.0

ICD-10 Finland

Haemangioma, any site

30.7

37.6

22701

ICD-8 Finland

Haemangioma and lymphangioma, Lymphangioma

+∞

35.2

2281A

ICD-9 Finland

Haemangioma and lymphangioma, any site, Lymphangioma, any site

+∞

33.0

QX3LT

NOMESCO Finland

Subcutaneous sclerotherapy

+∞

14.7

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

10.3

14.4

Q27.4

ICD-10 Finland

Congenital phlebectasia

+∞

11.5

22700

ICD-8 Finland

Haemangioma and lymphangioma, Haemangioma

114.5

10.5

XX6KT

NOMESCO Finland

Other sclerotherapy

+∞

10.5

EP1LT

NOMESCO Finland

Percutaneous sclerotherapy of vascular malformation of head and neck

+∞

10.5

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

9.6

441

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

103.7

9.5

Q27.9

ICD-10 Finland

Congenital malformation of peripheral vascular system, unspecified

+∞

9.4

ENB40

NOMESCO Finland

Excision of branchial cyst or fistula

93.0

8.5

4704

FHL

Neck tumor removal

+∞

8.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

12.4

7.7

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

+∞

7.3

Q27.88

ICD-10 Finland

Other specified congenital malformation of peripheral vascular system

+∞

7.3

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

16.3

7.3

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

12.5

7.2

S04

ICPC

Lump/swelling localized

3.1

6.5

119

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

71.6

6.5

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

7.3

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

8.60

7.62

1.4

2.0

113.0

121.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

17.19

6.79

1.3

3.0

129.1

145.5

—

(3023368) Bacteria identified in Blood by Culture

501

1.89

5.27

4.0

4.2

—

(3032080) INR in Blood by Coagulation assay

107

718

1.78

5.05

5.7

7.5

1.2

inr

0.08

234

(40768804) Tissue Pathology biopsy report

120

836

1.75

4.95

2.1

2.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

8.40

4.59

2.0

1.1

86.3

124.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

7.11

4.19

1.0

1.5

8.9

9.8

umol/l

—

(3022096) Basophils/100 leukocytes in Blood

141

1064

1.64

4.11

6.6

6.2

0.6

0.7

0.98

136

1005

(3013650) Neutrophils [#/volume] in Blood by Automated count

170

1351

1.64

3.97

10.2

9.1

3.9

4.0

e9/l

0.49

156

1186

(4306422)

3.54

3.95

1.3

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

144

1100

1.62

3.94

6.7

6.1

3.1

2.8

0.83

139

1039

(3002179) Metamyelocytes/100 leukocytes in Blood

152

2.17

3.62

2.7

4.5

0.0

0.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

137

1052

1.58

3.55

4.1

—

(3001604) Monocytes [#/volume] in Blood

149

1168

1.58

3.53

6.7

6.0

0.6

e9/l

0.53

141

1021

(3006315) Basophils [#/volume] in Blood

149

1171

1.57

3.47

6.7

6.0

0.0

e9/l

0.24

141

1024

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

3.20

3.41

1.5

1.3

6.2

3.9

u/ml

—

(3044640) Blood type and Crossmatch panel - Blood

681

1.59

3.25

2.7

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

5.45

3.21

1.3

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

152

1216

1.53

3.16

6.7

6.0

1.9

2.1

e9/l

0.70

145

1090

(3021440) Promyelocytes/100 leukocytes in Blood

154

2.06

3.13

3.0

4.7

0.0

0.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.89

3.13

1.1

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

128

1000

1.51

2.90

8.4

7.6

1.2

mmol/l

0.81

114

851

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.01

2.89

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

152

2.01

2.87

3.0

4.6

0.0

0.2

—

(3013115) Eosinophils [#/volume] in Blood

149

1207

1.49

2.80

6.9

6.3

0.2

e9/l

0.76

143

1079

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

116

894

1.50

2.78

2.7

2.4

77.5

73.6

nmol/l

0.79

109

810

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

193

1654

1.51

2.71

8.9

7.0

79.7

81.0

u/l

0.16

187

1549

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.80

2.58

1.3

1.0

—

(3002256) Pathology report gross observation

259

1.73

2.54

1.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

564

1.53

2.49

7.4

4.4

93.9

90.9

0.68

555

(3017181) Myelocytes/100 leukocytes in Blood

168

1.88

2.48

3.0

4.5

0.2

0.7

—

(3023520) Reticulocytes [#/volume] in Blood

146

1.94

2.47

2.1

3.6

60.7

73.9

e9/l

1.74

109

(4035726)

162

1.88

2.42

1.3

1.4

—

(4024509)

5.08

2.41

2.2

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.82

2.40

1.6

1.3

1.2

1.4

u/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

108

843

1.45

2.35

6.3

4.9

36.6

36.5

g/l

0.04

103

791

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

511

1.52

2.30

2.5

2.2

—

(3019225) pH of Specimen

165

1.84

2.29

5.7

4.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

151

1.87

2.25

8.0

4.6

0.8

1.2

mmol/l

0.25

111

(3022217) INR in Platelet poor plasma by Coagulation assay

197

1.76

2.24

16.0

20.1

1.2

inr

—

(3022313) Gas panel - Capillary blood

122

1.96

2.23

8.7

5.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

159

1.84

2.23

7.7

4.4

5.1

kpa

0.09

145

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

145

1.87

2.19

1.2

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.87

2.02

1.0

1.2

—

(40768797) Stomach Pathology biopsy report

277

1.61

1.99

1.3

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

4.60

1.95

3.8

2.6

24.4

27.3

umol/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

493

1.47

1.94

3.1

2.3

2.1

1.2

mg/l

0.39

377

(42870588) Differential panel, method unspecified - Blood

765

1.41

1.93

6.9

6.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

566

1.44

1.90

4.1

4.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.36

1.90

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.70

1.88

1.2

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.22

1.83

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.22

1.83

1.2

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.62

1.81

1.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

285

1.56

1.78

1.6

2.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.55

1.75

1.0

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

2.43

1.69

4.9

2.3

9.4

8.6

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.43

1.69

4.9

2.3

5.4

5.1

kpa

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.08

1.67

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.11

1.62

2.1

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.61

1.62

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.73

1.59

1.3

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.04

1.59

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.15

1.57

2.1

2.4

—

(40768443) Skin Pathology biopsy report

1.88

1.55

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.37

1.53

1.0

—

(40768441) Liver Pathology biopsy report

2.90

1.51

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

2.05

1.51

1.4

1.3

—

61.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

727

1.35

1.51

4.1

3.3

27.2

34.6

ng/l

0.32

433

(3007853) Bacteria identified in Skin by Aerobe culture

263

1.51

1.49

1.9

1.5

—

(1616796) Gas panel - Central venous blood

2.41

1.47

4.1

1.9

—

(40758558) Short blood count panel - Blood

594

1.36

1.42

6.8

6.7

—

(3012544) pH of Venous blood

224

1.53

1.41

3.3

6.3

—

(4062490)

2.64

1.37

1.0

1.3

—

(3019060) Gas panel - Arterial blood

113

1.73

1.35

3.6

8.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.17

1.35

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

145

1269

1.29

1.33

5.0

5.2

6.3

6.5

mmol/l

0.75

137

1156

(3002032) Base excess in Venous blood by calculation

219

1.52

1.33

3.4

6.2

1.7

1.6

mmol/l

0.03

161

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

219

2027

1.34

1.31

13.2

10.6

88.6

88.7

ml/min/173m2

0.03

189

1607

(3010421) pH of Blood

2.12

1.29

4.9

2.3

7.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.12

1.29

1.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

179

1.56

1.29

3.7

2.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

248

2345

1.43

1.26

15.5

12.0

26.0

22.1

mg/l

0.85

208

1772

(3004616) Nuclear Ab [Presence] in Serum

2.43

1.25

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.43

1.25

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

2.08

1.23

2.6

1.5

0.3

0.5

nmol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.19

1.22

1.3

1.9

—

(40768795) Lymph node Pathology biopsy report

2.66

1.22

1.2

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

311

1.41

1.19

1.4

285.7

451.1

titre

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

158

1.57

1.19

2.0

2.6

82.9

71.6

ml/min/173m2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.97

1.18

1.1

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

183

1.52

1.18

10.5

9.2

25.5

24.9

mmol/l

0.42

183

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.37

1.13

1.3

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

106

909

1.26

1.10

8.0

7.2

1.2

mmol/l

0.95

830

(4281824)

2.40

1.09

1.2

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.22

1.09

1.3

3.7

—

(3013512) EKG study

525

1.31

1.07

4.2

3.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

2.08

1.03

1.9

3.3

2.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.94

1.03

1.1

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.94

1.03

1.1

1.3

—

(3003396) Base excess in Arterial blood by calculation

215

1.44

1.02

4.7

10.0

-0.0

0.9

mmol/l

0.67

168

(1761482) Bacteria [#/volume] in Urine by Culture

1.92

1.02

5.6

3.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.02

1.00

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

313

1.36

0.99

1.7

1.8

—

(3000494) Fungus identified in Specimen by Culture

252

1.40

0.98

1.6

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

182

1675

1.24

0.96

4.3

3.8

10.6

10.2

mm/h

0.14

167

1532

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.91

0.94

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

239

2272

1.32

0.94

16.9

13.4

3.9

mmol/l

0.02

234

2192

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.25

0.94

1.0

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.66

0.92

1.9

2.3

38.9

42.6

u/l

0.31

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

102

0.48

0.91

1.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

195

1.42

0.90

1.4

1.2

69.0

145.7

iu/ml

—

(3037121) Protein [Mass/volume] in Urine

1.68

0.89

6.6

3.4

0.8

0.2

g/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

746

1.24

0.89

2.0

1.8

96.3

96.6

pmol/l

0.02

367

(3020891) Body temperature

1.70

0.86

4.8

4.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.96

0.85

1.3

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.78

0.84

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

165

0.59

0.84

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

1.58

0.83

4.3

3.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

362

1.29

0.78

2.0

1.7

417.9

449.4

pmol/l

0.41

309

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.72

0.76

1.3

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

190

1778

1.20

0.76

4.3

3.8

14.7

14.6

pmol/l

0.27

174

1630

(3022621) pH of Urine by Test strip

133

1.46

0.76

2.2

2.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.10

0.75

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.10

0.75

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.86

0.74

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

2.02

0.73

1.0

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.77

0.72

1.3

1.9

—

(3044889) 12 lead EKG panel

155

1430

1.18

0.71

3.2

3.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.58

0.69

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.66

0.69

1.4

316.8

285.6

ug/g

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.54

0.69

1.1

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.87

0.68

1.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.87

0.68

1.0

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.87

0.68

1.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.87

0.68

1.0

1.3

—

(44806118)

1.80

0.66

1.4

1.8

—

(44790049)

1.80

0.66

1.4

1.8

—

(44790048)

1.80

0.66

1.4

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.80

0.66

1.0

1.3

—

(44790047)

1.80

0.66

1.4

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

146

1.40

0.66

4.1

3.1

1.2

mmol/l

1.17

123

(3008898) HLA-B27 [Presence]

129

0.61

0.65

1.1

—

(4268621)

1.74

0.64

3.2

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.52

0.60

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.59

0.0

1.6

—

2.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

218

2086

1.19

0.59

3.8

3.6

1.2

1.3

mmol/l

1.56

208

1948

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.50

0.57

1.3

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.50

0.57

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

114

1040

1.16

0.57

10.9

8.7

0.0

e9/l

0.50

828

(3028026) IgM [Mass/volume] in Serum or Plasma

159

1.35

0.57

1.3

1.5

1.1

1.3

g/l

0.37

151

(3030981) Hyaline casts [#/volume] in Urine by Automated count

107

1.42

0.56

3.1

2.7

0.2

e6/l

0.01

101

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.47

0.56

1.3

1.8

—

(3017732) Neutrophils [#/volume] in Blood

152

1.34

0.53

1.7

2.9

4.1

3.9

e9/l

0.08

135

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

224

0.74

0.52

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

145

1.33

0.50

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

208

1.27

0.50

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

155

0.70

0.50

1.2

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

224

2161

1.17

0.48

4.2

3.9

1.5

mmol/l

0.52

213

2015

(3019832) Treponema pallidum Ab [Presence] in Serum

394

0.82

0.47

1.8

1.7

—

(3022145) Colonoscopy Study observation

219

1.26

0.47

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

455

0.83

0.45

4.5

4.1

1.6

1.8

ug/l

0.26

416

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

633

0.86

0.45

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.47

0.45

1.0

1.2

0.1

3.4

u/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

202

1939

1.14

0.44

5.5

4.9

38.5

38.7

mmol/mol

0.13

193

1820

(3003740) Influenza virus B Ag [Presence] in Specimen

1.38

0.44

1.6

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.38

0.44

1.6

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

744

1.14

0.44

3.4

3.1

—

(4094501)

1.39

0.42

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.52

0.41

2.2

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.41

0.0

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

227

2201

1.15

0.40

4.4

4.2

2.7

2.8

mmol/l

0.55

217

2049

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

103

0.67

0.40

1.1

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.36

0.40

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

681

1.14

0.40

3.8

3.1

2.3

2.4

mmol/l

0.27

591

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

191

1834

1.12

0.39

3.2

3.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

218

2110

1.14

0.39

4.9

4.5

1.6

1.8

mu/l

2.79

206

1956

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

471

1.15

0.38

2.1

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

226

1.21

0.37

1.5

1.7

—

(3021901) Oxygen saturation in Capillary blood

1.36

0.37

1.8

2.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.36

0.37

2.0

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1.36

0.37

1.2

1.6

—

(3026008) Bacteria identified in Urine by Culture

613

0.87

0.37

4.4

2.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

434

1.16

0.37

2.0

2.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

508

0.86

0.36

3.0

3.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.63

0.36

1.2

1.6

—

(1002224) Polysomnography panel

117

1.30

0.36

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.69

0.33

1.3

1.4

—

5.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.69

0.33

2.3

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.31

0.33

2.8

3.5

3.8

e9/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.31

0.33

3.3

3.9

55.5

54.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

623

1.12

0.32

3.5

2.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

316

1.16

0.31

1.9

1.7

1359.8

1222.5

nmol/l

0.23

233

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1.33

0.31

1.4

1.8

211.1

238.3

pmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

345

1.15

0.30

1.7

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

615

1.12

0.30

1.4

1.3

2.0

2.3

g/l

0.82

366

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.32

0.30

3.9

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

666

1.11

0.29

1.5

1.4

2.9

1.2

u/ml

0.43

160

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.29

0.28

1.6

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.31

0.28

1.5

1.2

—

(36304419) Bacteria [Presence] in Urine

611

0.90

0.28

3.1

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

826

1.09

0.26

3.6

3.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

223

2182

1.10

0.24

4.3

3.9

4.6

4.7

mmol/l

0.46

214

2047

(3000991) Gas panel - Venous blood

199

1.17

0.24

6.6

8.7

—

(40761511) CBC panel - Blood by Automated count

252

2481

1.13

0.24

15.7

10.5

—

(3014051) Protein [Presence] in Urine by Test strip

1.22

0.22

2.6

1.8

—

(3020650) Glucose [Presence] in Urine

0.00

0.21

0.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

4.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.8

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.2

—

(3016750) Collection duration of Urine

0.00

0.21

0.0

2.1

—

507.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3028433) Virus identified in Specimen by Culture

0.00

0.21

0.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.7

—

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

134

0.81

0.21

1.6

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

117

1.21

0.21

1.1

1.4

—

(4027681)

0.00

0.21

0.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.21

0.0

1.9

—

661.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.20

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.20

0.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.20

0.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

150

1547

0.94

0.19

5.0

3.9

—

(3019150) Specific gravity of Urine by Refractometry

484

1.09

0.19

3.3

3.2

1.0

kg/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.13

0.19

1.5

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

272

1.12

0.18

1.6

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

186

1.14

0.17

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

234

1.12

0.17

4.7

4.1

33.6

31.3

0.57

158

(40761535) Cells panel - Urine sediment

148

1.16

0.17

3.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.74

0.17

2.2

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

380

0.91

0.17

2.6

1.6

0.9

e6/l

0.38

205

(3052851) Hemolysis interference index of Serum or Plasma

1.16

0.16

1.6

3.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

139

1.16

0.16

1.4

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

420

1.08

0.16

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.76

0.16

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.74

0.15

2.0

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

401

1.09

0.15

1.3

10.6

22.4

iu/ml

2.12

126

(1761868) Lipid panel - Serum or Plasma

856

0.94

0.15

2.9

2.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.78

0.14

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

112

1.17

0.14

1.2

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

118

0.84

0.14

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

648

1.06

0.14

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

214

2107

1.06

0.14

4.4

3.8

5.8

mmol/l

0.01

201

1935

(3001019) Free T4 and TSH panel - Serum or Plasma

141

1.14

0.14

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

1.20

0.14

2.7

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

610

1.06

0.13

2.8

3.0

0.4

e6/l

0.04

448

(36660697) Celiac disease serology panel - Serum

242

0.90

0.13

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

365

0.92

0.13

3.2

3.7

16.9

22.1

1.31

130

(3002582) Erythrocytes [#/volume] in Urine

670

1.06

0.13

3.2

3.1

28.5

143.5

e6/l

0.61

505

(3015736) pH of Urine

878

1.05

0.13

3.4

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

364

0.93

0.12

2.6

2.8

1.2

2.8

e6/l

1.88

191

(3029937) Albumin [Presence] in Urine by Test strip

567

0.94

0.12

3.5

3.3

0.0

estimate

0.50

210

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

230

1.10

0.12

1.5

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

225

2276

0.95

0.11

16.3

13.1

39.7

40.5

0.79

179

1833

(21494755) Public health laboratory ask at order entry panel

301

0.92

0.11

1.3

—

(40761536) Microorganisms panel - Urine sediment

192

1.10

0.11

2.9

3.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.17

0.11

1.0

1.1

—

10.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

368

1.07

0.11

3.5

3.2

22.6

202.5

ng/l

2.39

254

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

388

1.07

0.10

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.06

0.09

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

233

1.08

0.09

6.4

6.0

—

(3009508) Creatinine [Moles/volume] in Urine

608

1.05

0.09

3.2

3.0

7.6

8.2

mmol/l

0.48

522

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

0.79

0.08

2.2

1.3

—

103.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.78

0.08

2.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

123

0.89

0.08

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

123

0.89

0.08

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

123

0.89

0.08

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

123

0.89

0.08

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.06

0.08

1.1

1.4

—

(4034850)

1.05

0.08

4.7

7.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.03

0.08

8.7

2.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

521

1.04

0.07

4.2

4.0

17.3

8.9

mg/mmol

0.38

336

(42529406) Shigella sp [Presence] in Stool by Culture

0.86

0.07

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.87

0.07

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

275

0.94

0.07

1.4

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

256

1.06

0.06

1.7

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

557

0.96

0.06

2.0

1.7

1.2

1.4

mmol/l

0.67

486

(4010399)

131

0.91

0.05

2.1

1.4

—

(3018418) pH of Serum or Plasma

596

0.97

0.05

4.9

3.6

7.4

0.22

104

(3018095) Leukocytes [#/volume] in Urine

797

0.97

0.05

3.9

3.7

64.5

62.1

e6/l

0.03

541

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

515

1.04

0.05

1.8

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

272

0.95

0.05

2.5

0.6

0.8

ug/l

1.20

153

(3035350) Ketones [Presence] in Urine by Test strip

108

1096

0.98

0.04

3.7

3.2

0.0

estimate

0.00

208

(3000764) Benzodiazepines [Presence] in Urine

170

1.06

0.04

1.2

1.8

—

(3003694) ABO and Rh group [Type] in Blood

733

0.98

0.03

1.5

—

(3027944) Amphetamines [Presence] in Urine

171

1.06

0.03

1.2

1.8

—

(3027008) Opiates [Presence] in Urine

171

1.06

0.03

1.2

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

152

1.06

0.02

1.5

1.3

—

49.7

—

(3028300) Cannabinoids [Presence] in Urine

172

1.05

0.02

1.2

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

112

1112

1.01

0.01

3.7

3.3

0.0

estimate

0.00

201

(3004588) Protein electrophoresis panel - Serum or Plasma

108

1.02

0.00

8.5

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

132

0.98

0.00

1.2

2.0

—

(3000492) Spirometry study

232

0.99

0.00

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

492

1.00

0.00

4.9

3.3

2322.2

315.5

mg/l

0.67

325

(3016879) Cocaine [Presence] in Urine

159

1.01

0.00

1.2

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

171

0.99

0.00

1.1

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

181

0.99

0.00

5.7

8.8

1.8

1.2

mmol/l

0.62

174

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.03

0.00

7.0

14.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

107

1.03

0.00

1.6

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

123

0.97

0.00

1.8

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

387

1.01

0.00

1.3

3.1

8.6

u/ml

1.06

150

(3005033) Fetal Nuchal fold Thickness US

105

1.05

0.00

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

105

1.05

0.00

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

215

0.97

0.00

1.4

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

114

0.96

0.00

1.0

1.4

270.7

292.9

miu/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

110

1095

1.01

0.00

5.5

4.6

0.0

estimate

0.00

214

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3048879) Bone marrow aspiration report

0.00

0.0

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

0.0

10.5

—

7.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

5.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

6.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.1

—

5.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.0

2.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

4.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.99

0.00

1.0

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

5.2

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.0

1.0

—

96.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

110

1.00

0.00

1.3

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

5.9

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

1.6

—

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.00

0.00

2.0

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

22.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

16.6

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

0.98

0.00

1.0

2.6

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.99

0.00

1.3

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.02

0.00

2.0

1.6

—

0.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.96

0.00

1.6

2.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LYMPHANGIOMA and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LYMPHANGIOMA	1.448 [1.07, 1.96]	0.017
Birth year	0.992 [0.98, 1.0]	0.092

During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 980 females with CD2_BENIGN_LYMPHANGIOMA died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LYMPHANGIOMA	1.548 [1.15, 2.08]	0.004
Birth year	0.985 [0.97, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 1096 males with CD2_BENIGN_LYMPHANGIOMA died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LYMPHANGIOMA.

N-year risk	Females	Males
1	0.107%	0.272%
5	0.651%	1.425%
10	1.786%	3.827%
15	3.482%	7.045%
20	6.277%	12.193%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LYMPHANGIOMA – Lymphangioma, anys site

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lymphangioma, anys site

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints